Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Nature Communications|February 16, 2022
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concernRana Abdelnabi, Caroline S Foo, Dirk Jochmans, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agentRoger G Ptak, Philippe A Gallay, Dirk Jochmans, et al.
ACS Infectious Diseases|February 7, 2018
Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-onesAsier Gómez-SanJuan, Ana-María Gamo, Leen Delang, et al.
Antiviral Research|February 19, 2024
Mechanism of action of phthalazinone derivatives against rabies virusVictoire Perraud, Bart Vanderhoydonck, Guillaume Bouvier, et al.
Journal of Medicinal Chemistry|September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main ProteaseMark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.
ACS Medicinal Chemistry Letters|May 16, 2022
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus ActivityMaria Giulia Nizi, Leentje Persoons, Angela Corona, et al.
Nature Genetics|March 9, 2021
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2Jim Baggen, Leentje Persoons, Els Vanstreels, et al.
Biochemical and Biophysical Research Communications|April 4, 2021
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster modelKoen Vandyck, Rana Abdelnabi, Kusum Gupta, et al.
Ebiomedicine|September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection modelRana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Ebiomedicine|January 17, 2024
Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warrantedDelphine Diana Acar, Wojciech Witkowski, Magdalena Wejda, et al.
Pageof 12